Average Co-Inventor Count = 4.09
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (33 from 174 patents)
33 patents:
1. 7179918 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
2. 7141587 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
3. 6953858 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
4. 6891044 - Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
5. 6884890 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
6. 6635641 - Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
7. 6534524 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
8. 6531491 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
9. 6525050 - (4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitors
10. 6323210 - Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
11. 6207670 - Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
12. 6001851 - HIV protease inhibitors
13. 5981748 - Synthesis of optically pure compounds useful as GARFT inhibitors and
14. 5945427 - Antiproliferative substituted 5-thiapyrimidinone and
15. 5885996 - Antiproliferative quinazolines